Dr. Miele Cosmed Group S.A. (WSE:DMG)
Poland · Delayed Price · Currency is PLN 2.250
-0.010 (-0.44%)
Jun 16, 2026, 1:21 PM CET
Dr. Miele Cosmed Group Income Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 499.56 | 504.21 | 488.35 | 444.48 | 396.57 | 351.87 | |
Revenue Growth (YoY) | 0.12% | 3.25% | 9.87% | 12.08% | 12.70% | -3.55% |
Cost of Revenue | 326.22 | 330.65 | 278.9 | 272.98 | 271.8 | 218.41 |
Gross Profit | 173.33 | 173.57 | 209.45 | 171.5 | 124.77 | 133.46 |
Selling, General & Admin | 3.55 | - | 124.98 | 105.06 | 94.46 | 94.93 |
Other Operating Expenses | 144.28 | 143.03 | 23.56 | 21.59 | 17.81 | 12.71 |
Operating Expenses | 148.39 | 143.03 | 161.1 | 138.61 | 123.6 | 118.28 |
Operating Income | 24.94 | 30.54 | 48.36 | 32.89 | 1.17 | 15.17 |
Interest Expense | - | - | -5.12 | -4.69 | -3.72 | -1.37 |
Interest & Investment Income | 1.94 | - | 0.28 | 0.12 | 0.18 | 0.12 |
Currency Exchange Gain (Loss) | - | - | -0.28 | -1.24 | 0.21 | -0.33 |
Other Non Operating Income (Expenses) | -5.55 | -5.55 | -0.14 | -0.04 | -0.08 | -0.21 |
EBT Excluding Unusual Items | 21.33 | 24.99 | 43.1 | 27.04 | -2.24 | 13.38 |
Gain (Loss) on Sale of Assets | - | - | 0.47 | 0.16 | 0.37 | -0.12 |
Asset Writedown | - | - | -0.21 | - | -0.23 | - |
Pretax Income | 21.33 | 24.99 | 43.36 | 27.2 | -2.1 | 13.26 |
Income Tax Expense | 5.1 | 5.3 | 7.37 | 4.98 | 0.17 | 1.66 |
Earnings From Continuing Operations | 16.23 | 19.69 | 35.99 | 22.22 | -2.27 | 11.6 |
Net Income to Company | 16.23 | 19.69 | 35.99 | 22.22 | -2.27 | 11.6 |
Net Income | 16.23 | 19.69 | 35.99 | 22.22 | -2.27 | 11.6 |
Net Income to Common | 16.23 | 19.69 | 35.99 | 22.22 | -2.27 | 11.6 |
Net Income Growth | -55.86% | -45.28% | 61.97% | - | - | -59.49% |
Shares Outstanding (Basic) | 85 | 86 | 87 | 87 | 87 | 87 |
Shares Outstanding (Diluted) | 85 | 86 | 87 | 87 | 87 | 87 |
Shares Change (YoY) | -2.19% | -1.74% | - | - | - | - |
EPS (Basic) | 0.19 | 0.23 | 0.41 | 0.25 | -0.03 | 0.13 |
EPS (Diluted) | 0.19 | 0.23 | 0.41 | 0.25 | -0.03 | 0.13 |
EPS Growth | -55.07% | -44.03% | 64.00% | - | - | -60.34% |
Free Cash Flow | - | - | 19.14 | 21.56 | -0.75 | 8.36 |
Free Cash Flow Per Share | - | - | 0.22 | 0.25 | -0.01 | 0.10 |
Dividend Per Share | - | - | 0.100 | 0.090 | - | 0.030 |
Dividend Growth | - | - | 11.11% | - | - | -50.00% |
Gross Margin | 34.70% | 34.42% | 42.89% | 38.58% | 31.46% | 37.93% |
Operating Margin | 4.99% | 6.06% | 9.90% | 7.40% | 0.29% | 4.31% |
Profit Margin | 3.25% | 3.91% | 7.37% | 5.00% | -0.57% | 3.30% |
Free Cash Flow Margin | - | - | 3.92% | 4.85% | -0.19% | 2.38% |
EBITDA | 39.63 | 44.66 | 58.16 | 42.47 | 10.69 | 24.29 |
EBITDA Margin | 7.93% | 8.86% | 11.91% | 9.55% | 2.70% | 6.90% |
D&A For EBITDA | 14.69 | 14.12 | 9.81 | 9.58 | 9.52 | 9.12 |
EBIT | 24.94 | 30.54 | 48.36 | 32.89 | 1.17 | 15.17 |
EBIT Margin | 4.99% | 6.06% | 9.90% | 7.40% | 0.29% | 4.31% |
Effective Tax Rate | 23.90% | 21.19% | 16.99% | 18.30% | - | 12.52% |